Level Four Advisory Services LLC grew its holdings in shares of DocuSign, Inc. (NASDAQ:DOCU – Free Report) by 2.3% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 106,826 shares of the company’s stock after purchasing an additional 2,370 shares during the period. Level Four Advisory Services LLC owned about 0.05% of DocuSign worth $9,608,000 as of its most recent SEC filing.
Other institutional investors also recently bought and sold shares of the company. Itau Unibanco Holding S.A. acquired a new position in shares of DocuSign during the 3rd quarter worth approximately $28,000. Kestra Investment Management LLC acquired a new stake in shares of DocuSign during the 4th quarter valued at $30,000. Brooklyn Investment Group purchased a new stake in DocuSign in the 3rd quarter worth approximately $33,000. Modus Advisors LLC bought a new stake in shares of DocuSign during the 4th quarter worth $36,000. Finally, First Horizon Advisors Inc. raised its holdings in DocuSign by 102.6% in the 4th quarter. First Horizon Advisors Inc. now owns 397 shares of the company’s stock valued at $36,000 after acquiring an additional 201 shares in the last quarter. 77.64% of the stock is owned by hedge funds and other institutional investors.
DocuSign Stock Performance
NASDAQ DOCU opened at $85.65 on Friday. DocuSign, Inc. has a one year low of $48.70 and a one year high of $107.86. The firm’s fifty day moving average is $87.30 and its two-hundred day moving average is $80.98. The firm has a market cap of $17.34 billion, a PE ratio of 17.66, a P/E/G ratio of 6.94 and a beta of 1.02.
Analyst Ratings Changes
DOCU has been the topic of several analyst reports. Bank of America cut their price objective on shares of DocuSign from $112.00 to $98.00 and set a “neutral” rating on the stock in a report on Friday, March 14th. Robert W. Baird set a $93.00 target price on shares of DocuSign in a report on Friday, March 14th. Royal Bank of Canada restated a “sector perform” rating and issued a $90.00 price target on shares of DocuSign in a research note on Friday, March 14th. UBS Group cut their target price on DocuSign from $100.00 to $90.00 and set a “neutral” rating on the stock in a report on Friday, March 14th. Finally, Piper Sandler boosted their target price on shares of DocuSign from $60.00 to $90.00 and gave the company a “neutral” rating in a research report on Friday, December 6th. Two research analysts have rated the stock with a sell rating, nine have assigned a hold rating and four have given a buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $95.00.
Get Our Latest Stock Report on DocuSign
Insider Buying and Selling at DocuSign
In related news, Director Teresa Briggs sold 534 shares of the firm’s stock in a transaction that occurred on Monday, March 17th. The shares were sold at an average price of $87.41, for a total transaction of $46,676.94. Following the completion of the sale, the director now directly owns 8,270 shares in the company, valued at approximately $722,880.70. This trade represents a 6.07 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO Allan C. Thygesen sold 40,000 shares of the stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $90.04, for a total value of $3,601,600.00. Following the completion of the transaction, the chief executive officer now owns 156,050 shares in the company, valued at $14,050,742. This represents a 20.40 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 97,851 shares of company stock worth $8,579,369 over the last quarter. 1.66% of the stock is owned by corporate insiders.
DocuSign Profile
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Featured Stories
- Five stocks we like better than DocuSign
- How to Invest in Insurance Companies: A Guide
- Penny Stock SurgePays Rises 70%: 1 Reason to Buy, 5 to Sell
- 3 Best Fintech Stocks for a Portfolio Boost
- Top 3 Beverage Stocks Pouring Out Profits
- Ride Out The Recession With These Dividend Kings
- CarMax and Carvana: Steering the Used Car Market
Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter.